环球印务(002799) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥696,925,501.44, representing a 10.03% increase compared to ¥633,419,466.40 in the same period last year[4] - Net profit attributable to shareholders was ¥28,729,049.41, up 4.84% from ¥27,402,907.36 year-on-year[4] - Total operating revenue for Q1 2023 reached ¥696,925,501.44, an increase of 10% compared to ¥633,419,466.40 in Q1 2022[22] - The net profit for Q1 2023 was CNY 32,498,774.16, an increase of 1.79% compared to CNY 31,925,678.59 in Q1 2022[24] - The total comprehensive income attributable to the parent company was CNY 28,729,049.41, an increase from CNY 27,402,907.36 in the previous year[24] - The basic earnings per share remained stable at CNY 0.09, unchanged from Q1 2022[24] Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥10,698,900.14, a decline of 141.46% compared to ¥25,807,505.26 in the previous year[4] - The cash flow from operating activities showed a net outflow of CNY -10,698,900.14, a significant decrease from the previous year's inflow of CNY 25,807,505.26[25] - The company reported a decrease in cash flow from operating activities, indicating potential challenges in cash generation[25] - The cash balance at the end of the reporting period is RMB 711,217,748.73, down from RMB 906,522,100.48 at the beginning of the year[19] - The cash and cash equivalents at the end of the period were CNY 682,889,219.70, down from CNY 233,565,112.62 at the end of Q1 2022[27] - The company incurred a cash outflow of CNY 73,790,814.76 in investment activities, compared to CNY 7,785,033.24 in the same period last year[27] - The cash flow from financing activities resulted in a net outflow of CNY -119,900,261.61, compared to CNY -61,006,303.84 in Q1 2022[27] Assets and Liabilities - Total assets decreased by 4.46% to ¥2,488,444,593.26 from ¥2,604,514,578.00 at the end of the previous year[4] - Accounts receivable increased to ¥546,801,168.93 from ¥451,360,796.25, showing a growth of about 21%[21] - Total liabilities decreased to ¥771,114,976.93 from ¥919,683,735.82, a decline of approximately 16.1%[21] - The company's equity attributable to shareholders increased by 1.81% to ¥1,614,835,921.90 from ¥1,586,106,872.49 at the end of the previous year[4] - The company's equity attributable to shareholders increased to ¥1,614,835,921.90 from ¥1,586,106,872.49, reflecting a growth of about 1.8%[21] Operational Metrics - Total operating costs amounted to ¥659,545,187.78, up from ¥601,879,022.53, reflecting a rise of approximately 9.6%[22] - The company incurred a credit impairment loss of ¥5,841,905.12, compared to a loss of ¥1,855,884.71 in the previous year[22] - Inventory decreased by 47.77% to ¥49,875,558.27, attributed to increased sales and reduced stocking[9] - Inventory decreased significantly to ¥49,875,558.27 from ¥95,500,351.74, a reduction of approximately 47.8%[21] - Research and development expenses were reported at ¥14,132,285.59, down from ¥16,502,638.89, a decrease of approximately 15.4%[22] Shareholder Information - The total number of common shareholders at the end of the reporting period is 20,804[12] - The largest shareholder, Shaanxi Pharmaceutical Holdings Group Co., Ltd., holds 36.42% of shares, totaling 116,550,000 shares[12] Investments and Projects - Cash paid for fixed asset purchases surged by 742.03% to ¥65,552,148.76, reflecting significant investments in key production equipment[10] - The company repaid bank loans amounting to ¥253,899,351.46, an increase of 89.16% compared to the previous year[10] - The company is constructing a green packaging smart manufacturing industrial park, which includes primary and secondary pharmaceutical packaging production centers and a technology R&D center[16] - The registered capital for the new materials project company in Tianjin is set to be no less than RMB 80 million, with a total investment of at least RMB 100 million[17] Other Information - The company maintained a stable capital reserve of ¥714,687,690.36, unchanged from the previous period[21] - The company has not disclosed any new product developments or market expansion strategies in this report[28]